Presenting Companies
BIOCOM's 2009 Investor Conference will include participation from over 65 public and private companies from Southern California and the Southwest who will present in 30-minute time slots throughout the two-day conference. These presentations will include companies from the following sectors: Biotech, Pharmaceutical, BioFuels, Medical Device and Innovation/PreSeries A. This is an unparalleled opportunity to gain exposure in front of 400+ key investors and industry executives.
Click here for a live audio webcasting of the presenting companies.
Please click HERE to view the presenting company schedule.
2009 Presenting Companies to include (by therapeutic area):
THERAPEUTIC COMPANIES
• Acadia (ACAD)
CNS
• Aethlon Medical
Infectious Disease
• Ambrx, Inc.B
Endocrine, CNS, Oncology
• Amira Pharmaceuticals, Inc.
Inflammatory Disease
• Amylin Pharmaceuticals, Inc. (AMLN)
• Anaptys Bio
Antibodies
• Arena Pharmaceuticals, Inc. (ARNA)
Cardiovascular, CNS, Inflammatory and Metabolic diseases
• Avanir Pharmaceuticals (AVNR)
CNS
• BrainCells Inc.
CNS
• Burnham Institute for Medical Research
Drug Discovery
• Cadence Pharmaceuticals (CADX)
Pain Management, Infectious Disease, Anesthesia and Cardiology
• Cequent Pharmaceuticals, Inc.
RNAinterference
• Conatus Pharmaceuticals
Small Molecule Therapeutics For Liver Disease
• Cytori Therapeutics (CYTX)
Regenerative Medicine
• GlobeImmune, Inc.
Cancer & Infectious Diseases
• Halozyme Therapeutics (HALO)
Oncology, Metabolic, Dermatology
• Helixis, Inc.
MolecularDiagnostics
• Inovio Biomedical Corporation (INO)
Vaccines
• Inhibikase Therapeutics
Infectious Disease
• ISIS Pharmaceuticals, Inc. (ISIS)
Cardiovascular, etc.
• ISTA Pharmaceuticals, Inc. (ISTA)
Ophthalmic pharmaceuticals
• KAER Biotherapeutics
Drug Delivery Through the Respiratory System
• Kinagen, Inc.
Cancer, Cardiovascular, Inflammatory and fibrotic diseases
• Lithera, Inc.
AestheticMedicine
• Lpath, Inc. (LPTN)
MonoclonalAntibodies for cancer and retinal diseases
• Mpex Pharmaceuticals, Inc.
Respiratory & Infectious Disease
• Multimeric Biotherapeutics, Inc.
Vaccines and cancer therapy
• NexBio
Infectious Disease, Biodefense, Platform Technology
• Optimer Pharmaceuticals (OPTR)
Anti-infectives
• Orexigen Therapeutics, Inc. (OREX)
Obesity
• Otonomy
Otic Disorders
• Regulus Therapeutics Inc.
Viral Infection, Oncology, Inflammatory Disease, Metabolic Disease
• SeneXta Therapeutics SA
CNS
• Spectrum Pharmaceuticals, Inc. (SPPI)
Oncology
• Theregen, Inc.
Coronary Artery Disease/Heart Failure
• TRACON Pharmaceuticals, Inc.
Oncology
• Transdel Pharmaceuticals, Inc. (TDLP.OB)
Specialty Pharma, Topical Delivery Of Therapeutics
• VentiRx
Oncology, Respiratory, Autoimmune
• Vical Inc. (VICL)
Vaccines
• Zacharon Pharmaceuticals
Therapeutics & Diagnostics for Oncology & Lysosomal Storage Disease
DIAGNOSTICS
• Adnavance
Molecular Diagnostics
• DermTech
Molecular Diagnostics (non-invasive)
• Enigma Diagnostics
Decentralised and Point of Care Molecular Diagnostics
• Gen-Probe Incorporated (GPRO)
Molecular Diagnostics
• LineaGen, Inc.
Autism and MS Diagnostics
• Microparticle Proteomics LLC (MPP)
Biomarkers
SERVICES & TOOLS
• Althea Technologies
CMO
• GenWay Biotech, Inc.
Dx
• Life Technologies (LIFE)
Personalizedmedicine, regenerative science, molecular diagnostic
DEVICES & IMAGING
•Alphatec Spine (ATEC)
Spinal Disorder Medical Device Solutions
•Digirad, Inc. (DRAD)
Cardiology Imaging
•GlySens Incorporated
Diabetes, Continuous Glucose Monitoring, Metabolic Monitoring
•NuVasive (NUVA)
Spine
•Volcano Corp. (VOLC)
Cardiovascular Disease
FOOD, AG & CLEAN TECHNOLOGY
•Genomatica
Sustainable Chemicals Producer
•Sapphire Energy, Inc.
Biofuels
•Senomyx, Inc. (SNMX)
Food Ingredients
•Verenium (VRNM)
Biofuels & Specialty Enzymes
•VetStem
Regenerative Veterinary Medicine
INFORMATION FOR PRESENTING COMPANIES:
Press Release Opportunity:
PR Newswire is offering a complimentary news release of up to 400 words to BIOCOM members who are presenting at the upcoming 2009 BIOCOM Investor Conference. Presenters have the opportunity to notify media throughout southern California, along with the investment community, key biotech trades and online services about their participation in the conference. All releases will also be posted to more than 5,000 online services and databases, and to PR Newswire.com, PR Newswire's award-winning website, as well as PR Newswire for Journalists, the media-only website with more than 90,000 registered journalists. PR Newswire membership is free to BIOCOM members.
Contact Jane Booth at PR Newswire for more information, 858-720-0337. Or email: jane.booth@prnewswire.com
Ask IMS Opportunity:
As a sponsor of the 2009 BIOCOM Investor Conference, IMS Health is pleased to offer companies making Investor Presentations access to our "Ask IMS" service. Click HERE for more details.